Loading provider…
Loading provider…
Hematology & Oncology Physician in Grand Rapids, MI
NPI: 1104023118Primary Practice Location
SPECTRUM HEALTH
1840 Wealthy St Se, Grand Rapids, MI
Primary Employer
Chc - East
thechc.com
HQ Phone
Get MD Binu's Phone Numberphone_androidMobile
Get MD Binu's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
MI State Medical License

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 230 | 490 |
| 2 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 122 | 190 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 98 | 233 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 63 | 74 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 47 | 47 |
Authors: Gregory Kalemkerian, Bryan Schneider, Angel Qin, Shirish Gadgeel, Nithya Ramnath
Journal: Clin Lung Cancer
Publication Date: 2023-10-26
Evaluation of EGFR mutation status in cytology specimens: an institutional experience.
Authors: Corey Langer, Zubair Baloch, Tracey Evans
Journal: Diagn Cytopathol
Publication Date: 2011-11-18
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Placebo, OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Oxaliplatin, DRUG: Duloxetine, DRUG: Duloxetine Hydrochloride
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: Canadian Cancer Trials Group
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Nivolumab, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, PROCEDURE: X-Ray Imaging, PROCEDURE: Biopsy Procedure, OTHER: Patient Observation, PROCEDURE: Colonoscopy, PROCEDURE: Sigmoidoscopy, PROCEDURE: Digital Rectal Examination, PROCEDURE: Proctoscopy, PROCEDURE: High Resolution Anoscopy
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Fluorouracil, PROCEDURE: Computed Tomography, DRUG: Oxaliplatin, DRUG: Leucovorin Calcium